Stay updated on Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial page.

Latest updates to the Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page update adds a PubMed auto-fill note indicating publications are drawn from PubMed and may not pertain to the study, and it also introduces a revision tag (v3.3.2). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check28 days agoChange DetectedThe government funding lapse notice regarding NIH operations was removed from the page.SummaryDifference0.1%

- Check42 days agoChange DetectedNo new or removed content on the Study Details page for NCT02597933. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange Detected- Added a government-operating-status notice and a link to official sources; updated to v3.2.0. - Removed a specific resource on Systemic sclerosis and old version tag v3.1.0.SummaryDifference2%

- Check78 days agoChange DetectedAdded a new 2025 Scleroderma lung disease article citation and updated version to v3.1.0; removed an older ahead-of-print citation and several drug-safety category tags (likely a cleanup of categories).SummaryDifference0.4%

- Check92 days agoChange DetectedVersion bump from v3.0.1 to v3.0.2; no substantive content changes detected. The removal of 'Back to Top' is a minor UI change.SummaryDifference0.1%

Stay in the know with updates to Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial page.